Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
Clinical trial NCT06238921 · RECRUITING
Trial details
- NCT number
- NCT06238921
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-19
- Primary completion
- 2027-02-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.